Largest market shown
Germany
$153.9B calculated opportunity across 55 screened products.
Regional export playbook
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Europe regional view
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Largest market shown
$153.9B calculated opportunity across 55 screened products.
Regional footprint
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $153.9B | 55 | Reported | 8,793 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United KingdomGBR | $107.1B | 24 | Reported | 9,249 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| NetherlandsNLD | $96.5B | 24 | Reported | 8,892 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, LiechtensteinCHE | $81.3B | 10 | Not reported | 8,936 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $67.6B | 24 | Reported | 9,209 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| BelgiumBEL | $59.0B | 10 | Reported | 8,990 km | 5 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| SpainESP | $19.2B | 8 | Reported | 10,053 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| PolandPOL | $18.5B | 11 | Reported | 7,841 km | 37 | Telephones for cellular networks or for other wireless networks |
| CzechiaCZE | $17.5B | 8 | Reported | 8,339 km | 25 | Telephones for cellular networks or for other wireless networks |
| ItalyITA | $16.1B | 7 | Reported | 8,742 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| RussiaRUS | $15.6B | 9 | Not reported | 6,738 km | 10 | Telephones for cellular networks or for other wireless networks |
| SloveniaSVN | $14.2B | 3 | Reported | 8,453 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| IrelandIRL | $8.5B | 3 | Reported | 9,520 km | 11 | Electronic integrated circuits: processors and controllers, whether or not combined with memories, converters, logic circuits, amplifiers, clock and timing circuits, or other circuits |
| GreeceGRC | $8.1B | 3 | Reported | 7,930 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| AustriaAUT | $7.4B | 4 | Reported | 8,255 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| MaltaMLT | $5.8B | 2 | Reported | 8,780 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| SwedenSWE | $5.1B | 3 | Reported | 7,893 km | 8 | Vehicles: with only electric motor for propulsion |
| HungaryHUN | $2.9B | 2 | Reported | 8,078 km | 7 | Telephones for cellular networks or for other wireless networks |
| SlovakiaSVK | $2.7B | 2 | Reported | 8,198 km | 22 | Vehicles: parts and accessories, of bodies, other than safety seat belts |
| DenmarkDNK | $2.4B | 2 | Reported | 8,300 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| NorwayNOR | $1.5B | 1 | Not reported | 8,283 km | 4 | Product not reported |
| UkraineUKR | $1.4B | 1 | Not reported | 7,206 km | 7 | Product not reported |
| RomaniaROU | $1.2B | 1 | Not reported | 0 km | 0 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
Top regional opportunities
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | BelgiumBEL | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $20.7B | +7.6% | +0.0% |
| 4 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.1% |
| 5 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 6 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $17.3B | +12.8% | +0.0% |
| 7 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 8 | United KingdomGBR | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $14.4B | +5.5% | +0.0% |
| 9 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 10 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.0% |
| 11 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 12 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 13 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 14 | BelgiumBEL | HS 300220Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
| 15 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.0B | +3.5% | +4.0% |
| 16 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $7.8B | +9.2% | +10.4% |
| 17 | NetherlandsNLD | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.1B | +4.0% | +1.9% |
| 18 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 19 | FranceFRA | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $6.3B | +3.8% | +0.1% |
| 20 | FranceFRA | HS 870380Vehicles: with only electric motor for propulsion | $6.2B | +31.1% | +0.0% |
Sector opportunities
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 30
30 screened products with $269.5B of reported buyer imports.
$126.6BCalculated opportunity · +10.9% average growthHS2 85
46 screened products with $221.0B of reported buyer imports.
$124.6BCalculated opportunity · +12.1% average growthHS2 71
11 screened products with $214.7B of reported buyer imports.
$80.6BCalculated opportunity · +11.5% average growthHS2 00
20 screened products with $192.4B of reported buyer imports.
$79.4BCalculated opportunity · +8.2% average growthHS2 27
10 screened products with $155.4B of reported buyer imports.
$76.8BCalculated opportunity · +12.0% average growthHS2 84
24 screened products with $110.7B of reported buyer imports.
$69.6BCalculated opportunity · +7.6% average growthHS2 87
25 screened products with $125.2B of reported buyer imports.
$56.7BCalculated opportunity · +15.7% average growthHS2 88
5 screened products with $35.0B of reported buyer imports.
$16.9BCalculated opportunity · +7.9% average growthFrequently asked questions
Practical guidance for interpreting regional market and product comparisons.
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.